VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 112 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,374,000 | -30.6% | 148,900 | -27.6% | 0.02% | -28.0% |
| Q3 2016 | $3,420,000 | +63.3% | 205,600 | +9.9% | 0.02% | +47.1% |
| Q2 2016 | $2,094,000 | +329.1% | 187,100 | +220.4% | 0.02% | +325.0% |
| Q1 2016 | $488,000 | +378.4% | 58,400 | +430.9% | 0.00% | +300.0% |
| Q4 2015 | $102,000 | +78.9% | 11,000 | +144.4% | 0.00% | 0.0% |
| Q2 2015 | $57,000 | -52.5% | 4,500 | -65.1% | 0.00% | 0.0% |
| Q1 2015 | $120,000 | -28.6% | 12,900 | +24.0% | 0.00% | -50.0% |
| Q2 2014 | $168,000 | +441.9% | 10,400 | +447.4% | 0.00% | – |
| Q1 2014 | $31,000 | -86.6% | 1,900 | -93.4% | 0.00% | -100.0% |
| Q2 2013 | $232,000 | +35.7% | 28,604 | -34.3% | 0.00% | +50.0% |
| Q1 2013 | $171,000 | – | 43,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |